Navigation Links
Keryx Biopharmaceuticals Announces Poster Presentations Highlighting Clinical Activity of KRX-0401 (Perifosine) at the Upcoming Annual Meeting of the American Society of Clinical Oncology
Date:5/18/2009

Results Will be Reported from Phase 2 Studies Evaluating KRX-0401 in Advanced Renal Cell Carcinoma, Colorectal Cancer and Gastrointestinal Stromal Tumors (GIST)

NEW YORK, May 18 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that four abstracts on KRX-0401 (Perifosine), the Company's Akt-inhibitor for cancer, were accepted for presentation during poster sessions taking place at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO), to be held in Orlando, Florida from May 29 to June 2.

All of the clinical data to be presented demonstrates the potential clinical efficacy of KRX-0401, both as a single agent and in combination with other approved agents, in the treatment of patients with advanced renal cell carcinoma, colorectal cancer and GIST.

Abstracts selected for presentation are as follows:

Renal Cell Carcinoma (RCC)

Friday, May 29th, 2009:

#5034: Phase II study of perifosine in metastatic renal cell carcinoma (RCC) progressing after prior therapy (Rx) with a VEGF receptor inhibitor.

Lead Author: Nicholas Vogelzang, MD

Poster Discussion: 5:00pm-6:00pm (Level 2, West Hall F5)

Sunday, May 31st, 2009:

#5101: A phase II trial of perifosine in patients with advanced renal cell carcinoma (RCC) who have failed tyrosine kinase inhibitors (TKI).

Lead Author: Daniel Cho, MD

Poster Session: 2:00pm - 6:00pm (Level 2, West Hall C)

Colorectal Cancer

Sunday, May 31st, 2009:

#4081: Randomized pha
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on First Quarter 2009 Financial Results on Thursday, May 14, 2009 at 8:30am EDT
2. Keryx Biopharmaceuticals, Inc. Announces Michael P. Tarnok as Interim Chairman and Chief Executive Officer
3. Keryx Biopharmaceuticals Presents Encouraging Preclinical Data at Annual Meeting of the American Association of Cancer Research
4. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2008 Financial Results
5. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2008 Financial Results on Friday, March 13, 2009 at 8:30am EDT
6. Keryx Biopharmaceuticals Inc. Announces Receipt of Nasdaq Delisting Notification
7. Keryx Biopharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference
8. Keryx Biopharmaceuticals Notified that Nasdaq Has Extended Minimum Bid Price Rule Compliance Period
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
10. Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference
11. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...SSISSAUGA,ON,Nov.23/PRNewswire-FirstCall/-YMBioSci...uctdevelopmentcompanythatidentifiesandadvancesadiv...riousstagesofdevelopment,todayreportedthatCytopia(...luatingCYT387,apotent,orally-administeredJAK1/JAK2...chester,Minnesota.AproposaltomergeCytopiaintoYMhas...
(Date:11/23/2009)...ATTLE,Nov.23/PRNewswire/--ImmuneDesignC or p.(IDC)...ExecutiveChairman.Dr.Carterhasasuccessfultrackrec ...r merChiefExecutiveOfficeratZymoGenetics,inSeattle...agen,Denmark. ,, (Photo: http://www.newscom.com...ed,IDC,sfounderandChiefExecutiveOfficercommented,"...
(Date:11/23/2009)...DWOODCITY,Calif.,Nov.23/PRNewswire/--PearlTherapeu...euticproductsforthetreatmentofchronicrespiratorydi...hecompany,sBoardofDirectors.Mr.Rosenhas25yearsofex...ies,includingkeyrolesatGileadSciencesandALZACorpor...nPearl,sBoardtosix. ,, "Howiebringsawealthofpro...
(Date:11/20/2009)...d Latin American countries have an opportunity to ...Researchers from the University of Valencia (UV), ... studied the productive fabric of the Spanish biot...,s food and plant sectors have more clout than tho...y as applied to food and plants has been overlooke...
Breaking Biology Technology:YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2Spanish biotechnology should focus on food and plant sectors to be more competitive 2
.... - One of the most active legislative periods fr...e, and a key legislator says the state has no more...sed economy. , ,State Senator Ted Kanavas , R-Bro...re,s technology work is done, but with the signing...redit bills, he said the major hurdles have been c...
... recently interviewed Robert M. Price about his bo...ies and Managing the Creative Enterprise". This co...y, innovation and "the `C, word". , ,"At its most...out people." , ,Not surprisingly, Price,s people .... (CDC) from a hardware-only firm to a service com...
...rticle, we looked at the leading pharmaceutical co...al market, which for the first time surpassed $60...t of equation, as another significant market is th... numbers on the size of the total medical device m...$200 billion in annual revenue in 2005, as the top...
Other Biology Technology:Kanavas says Wisconsin has no more excuses 2Kanavas says Wisconsin has no more excuses 3Kanavas says Wisconsin has no more excuses 4New book from former CDC CEO walks readers through innovation 2New book from former CDC CEO walks readers through innovation 3New book from former CDC CEO walks readers through innovation 4Midwest retains dominant role in 2005 world medical device market 2Midwest retains dominant role in 2005 world medical device market 3Midwest retains dominant role in 2005 world medical device market 4Midwest retains dominant role in 2005 world medical device market 5Midwest retains dominant role in 2005 world medical device market 6Midwest retains dominant role in 2005 world medical device market 7
(Date:11/24/2009)...r of debate. A high-profile study a few years ago ... carbon from trees and leaves, evidence for a very...osystems. , But new research from the University.... Algae provide a much richer diet for fish and ot...this week in the Proceedings of the National Acad...
(Date:11/23/2009)... evidence that the "synergistic" effect of early-l...tion and indoor endotoxin causes more harm to deve... , Environmental health scientists at the Univ... shown that children exposed to both high levels o...uring early life are six times more likely to expe...
(Date:11/23/2009)...e of day matters to forest trees dealing with drou...ch team led by Professor Malcolm Campbell, Univers...search and colleagues in the department of cell an...Capitalizing on their previous work to decode the ...ned how poplar trees use their 45,000 genes to res...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Time of day matters to thirsty trees, U of T researcher discovers 2Uphold the ban 9189 1Survey 3A Speech Therapy Helps But People Who Stutter Suffer Discrimination 51213 1Survey 3A Speech Therapy Helps But People Who Stutter Suffer Discrimination 51213 2Echo Therapeutics To Present at Prestigious Innovations in Diabetes Conference 51208 1Echo Therapeutics To Present at Prestigious Innovations in Diabetes Conference 51208 2Echo Therapeutics To Present at Prestigious Innovations in Diabetes Conference 51208 3
...ds in Sydney Harbour could be threatening the smal...udy revealing that the harbour,s seaweeds have the...nation. , Up to 75 percent of the offspring of sm...d, for example, are killed when they are exposed t...our, UNSW laboratory and field experiments have sh...
...nd. - A new, high-resolution, interactive map of U... found that the emissions aren,t all where we thou...any emissions to the northeastern United States, a...ch larger source than we had estimated previously,...th and atmospheric science at Purdue University an...
...ott A. Strobel, Professor of Molecular Biophysics ... Schering-Plough Research Institute Award. , The ... and Molecular Biology to recognize outstanding sc...arly in their careers. , Strobel will give the aw...Ribozymes, Ribosomes, and Riboswitches, at the soc...
Other Biology News:Sydney harbors deadly diet for sea creatures 2'Revolutionary' CO2 maps zoom in on greenhouse gas sources 2'Revolutionary' CO2 maps zoom in on greenhouse gas sources 3'Revolutionary' CO2 maps zoom in on greenhouse gas sources 4'Revolutionary' CO2 maps zoom in on greenhouse gas sources 5Yale University's Strobel recognized for work on RNA 2
...combinant 177 amino acid polypeptide sequence corr.... Produced by activation of a recombinant soluble...m. SPECIFIC ACTIVITY:The specific activity of MT1... the activity that hydrolyzes 1 mol peptide (7-met...
...s a compact, lightweight, high current power suppl...liamps. It is an excellent choice for PAGE, SDS-PA... for all types of electroblotting applications.A d...ally end a run and wil automatically accrue elapse...
Anti-Interferon-beta (IFNb) Monoclonal Antibody, Unconjugated from CHEMICON
...rigerated Vapor Trap Models RVT100, RVT400, RVT405...els UVS400, UVS400A and UVS800DDA., A non-corrosi... suitable for use for temperatures ranging from -1... thermal stability and does not evaporate. Far sup...
Biology Products: